Metraipolis › archive › dc_02aefb896774

Interstitial Lung Disease in Patients With Unresectable Stage III NSCLC Treated With Chemoradiotherapy Followed by Durvalumab in Japan: Analysis From the… — Europe PMC PMID:42152809

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42152809
DOI
10.1111/1759-7714.70299
License (as archived)
solo-consultazione
Archived
2026-10-17T11:13:29.123Z
SHA-256 of the archived text
e5aca9de0d7e5313d728d37f3b7dc391c1cbafb465332ff2debddd9fd5cbfb15
Stable URL of this page
https://metraipolis.com/documento/dc_02aefb896774

How to cite

Interstitial Lung Disease in Patients With Unresectable Stage III NSCLC Treated With Chemoradiotherapy Followed by Durvalumab in Japan: Analysis From the… — Europe PMC PMID:42152809 — Europe PMC (en), https://europepmc.org/article/MED/42152809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02aefb896774 (Metraipolis archive dc_02aefb896774, sha256 e5aca9de0d7e5313d728d37f3b7dc391c1cbafb465332ff2debddd9fd5cbfb15)
BibTeX
@misc{dc02aefb896774,
  title = {Interstitial Lung Disease in Patients With Unresectable Stage III NSCLC Treated With Chemoradiotherapy Followed by Durvalumab in Japan: Analysis From the… — Europe PMC PMID:42152809},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42152809},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02aefb896774; sha256 e5aca9de0d7e5313d728d37f3b7dc391c1cbafb465332ff2debddd9fd5cbfb15},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42152809. Agents can read the archived copy with the MCP tool read_document.